Page last updated: 2024-09-03

20-hydroxy-5,8,11,14-eicosatetraenoic acid and Diabetes Mellitus

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Diabetes Mellitus in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Azar, ST; Azar, TS; Azar, WS; Eid, AA; Hamdy, AF; Houeiss, P; Njeim, R; Noureldein, M; Rashid, A; Tamim, H; Zeidan, YH1
Jakstas, V; Kupstyte-Kristapone, N; Lesauskaite, V; Tatarunas, V; Zaliunas, R; Zvikas, V1
Xie, XN; Zhang, DH; Zhu, Y1
Bass, A; Edin, ML; Ellis, K; Hinderliter, AL; Lee, CR; Lih, FB; Poloyac, SM; Schuck, RN; Stouffer, GA; Theken, KN; Tomer, KB; Tran, B; Wu, MC; Zeldin, DC1
Abraham, NG; Gotlinger, KH; Guo, A; Hochhauser, E; Issan, Y; Kornowski, R; Laniado-Schwartzman, M; Leshem-Lev, D; Lev, E; Porat, E; Snir, E; Thompson, CI1
Carroll, MA; Ferreri, NR; McGiff, JC; Quilley, J1

Reviews

2 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Diabetes Mellitus

ArticleYear
[Progress in research of arachidonic acid-cytochrome P450 pathway in diabetes].
    Sheng li ke xue jin zhan [Progress in physiology], 2011, Volume: 42, Issue:4

    Topics: Animals; Arachidonic Acid; Cytochrome P-450 Enzyme System; Diabetes Mellitus; Humans; Hydroxyeicosatetraenoic Acids; Insulin Resistance

2011
Renal COX-2, cytokines and 20-HETE: tubular and vascular mechanisms.
    Current pharmaceutical design, 2004, Volume: 10, Issue:6

    Topics: Animals; Cyclooxygenase 2; Cytokines; Diabetes Mellitus; Glucocorticoids; Humans; Hydroxyeicosatetraenoic Acids; Ion Transport; Isoenzymes; Kidney; Kidney Tubules; Membrane Proteins; Microcirculation; Prostaglandin-Endoperoxide Synthases; Receptors, Calcium-Sensing; Tumor Necrosis Factor-alpha

2004

Other Studies

4 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Diabetes Mellitus

ArticleYear
Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease.
    Journal of advanced research, 2023, Volume: 44

    Topics: Diabetes Mellitus; Diabetic Nephropathies; Humans; Kidney; Prognosis; Prospective Studies

2023
Factors associated with platelet reactivity during dual antiplatelet therapy in patients with diabetes after acute coronary syndrome.
    Scientific reports, 2020, 02-21, Volume: 10, Issue:1

    Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Blood Platelets; Cytochrome P450 Family 4; Diabetes Mellitus; Female; Humans; Hydroxyeicosatetraenoic Acids; Logistic Models; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors

2020
Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
    Atherosclerosis, 2012, Volume: 222, Issue:2

    Topics: 8,11,14-Eicosatrienoic Acid; Age Factors; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Diabetes Mellitus; Eicosanoids; Epoxide Hydrolases; Female; Humans; Hydroxyeicosatetraenoic Acids; Hydroxylation; Male; Middle Aged; North Carolina; Obesity; Regression Analysis; Risk Assessment; Risk Factors; Severity of Illness Index; Smoking; Tandem Mass Spectrometry

2012
Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia.
    Prostaglandins & other lipid mediators, 2013, Volume: 100-101

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; AC133 Antigen; Aged; Antigens, CD; Body Mass Index; Cell Survival; Chromatography, Liquid; Diabetes Mellitus; Eicosanoids; Endothelial Cells; Female; Flow Cytometry; Glycoproteins; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipids; Male; Middle Aged; Myocardial Ischemia; Peptides; Stem Cells; Tandem Mass Spectrometry; Vascular Endothelial Growth Factor Receptor-2

2013